Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |